SENSEX
NIFTY
GOLD
USD/INR

Weather

image 29    C

National News

The Times of India

National / The Times of India

details

When cost stops being the barrier: The new chapter of Ozempic injection in India

The upcoming patent expiry for Ozempic in India is set to dramatically lower the cost of semaglutide, making this once-premium diabetes and weight-loss drug accessible to more patients. This shift could reshape the market, prompting earlier prescriptions and potentially altering societal views on weight management and body acceptance.

7 Mar 2026 1:17 pm